Hologic Inc. Files 8-K: Officer/Director Changes & Financials

Ticker: HOLX · Form: 8-K · Filed: Apr 6, 2026 · CIK: 0000859737

Sentiment: neutral

Topics: officer-changes, director-changes, financials

TL;DR

Hologic 8-K: Leadership changes, other events, and financials filed April 6, 2026.

AI Summary

Hologic Inc. announced on April 6, 2026, changes related to its officers and directors, as well as other events and financial statements. The filing details Item 5.02 concerning departures and appointments of officers and directors, Item 8.01 for other material events, and Item 9.01 for financial statements and exhibits. Specific details on the compensatory arrangements of certain officers are also included.

Why It Matters

This filing indicates potential shifts in leadership or strategic direction within Hologic Inc., which could impact its future operations and stock performance.

Risk Assessment

Risk Level: medium — Changes in officers or directors can signal strategic shifts or internal issues that may affect the company's performance.

Key Players & Entities

FAQ

What specific changes were made regarding officers and directors?

The filing indicates Item 5.02 covers departures of directors or certain officers, election of directors, and appointment of certain officers, along with compensatory arrangements for certain officers.

What is the significance of Item 8.01 in this filing?

Item 8.01 pertains to 'Other Events,' suggesting that Hologic Inc. is disclosing other material information not covered by other standard 8-K items.

What type of financial information is included under Item 9.01?

Item 9.01 covers 'Financial Statements and Exhibits,' which typically includes any required financial statements and supporting documentation.

When was this 8-K filing accepted by the SEC?

This 8-K filing was accepted on April 6, 2026, at 08:00:56.

What is Hologic Inc.'s business address and phone number?

Hologic Inc.'s business address is 250 CAMPUS DRIVE MARLBOROUGH MA 01752, and their phone number is 5082632900.

Filing Stats: 1,139 words · 5 min read · ~4 pages · Grade level 13.4 · Accepted 2026-04-06 08:00:56

Filing Documents

02

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 6, 2026, Stephen P. MacMillan informed the Board of Directors of Hologic, Inc. (the "Company") of his retirement as President and Chief Executive Officer and as Chairman of the Board of Directors of the Company, contingent upon, and effective as of immediately after, the closing of the acquisition of the Company by affiliates of funds managed by Blackstone Inc. and TPG Global, LLC pursuant to the Agreement and Plan of Merger, dated October 21, 2025, by and among the Company, Hopper Parent Inc. and Hopper Merger Sub Inc (the "Merger"). A copy of the Company's press release announcing Mr. MacMillan's retirement is filed with this Current Report on Form 8-K as Exhibit 99.1.

01

Item 8.01 Other Events. On April 6, 2026, the Company announced it has received all regulatory approvals necessary to complete the Merger. The transaction is expected to close on or about April 7, 2026, subject to the satisfaction or waiver of customary closing conditions. Cautionary Statement Regarding Forward-Looking Statements This Current Report on Form 8-K includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," "estimates," "projects," "predicts," "likely," "future," "strategy," "potential," "seeks," "goal" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the benefits of and timeline for closing the merger. These forward-looking statements are based upon assumptions made by Hologic as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements are subject to a number of risks and uncertainties that could adversely affect Hologic's business and prospects, and otherwise cause actual results to differ materially from those anticipated, including without limitation, the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement entered into in connection with the proposed transaction; the risk that the parties to the merger agreement may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all; risks related to disruption of management time from ongoing business operations due to the proposed transac

Financial Statements and Exhibits

Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Press Release dated April 6, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 6, 2026 HOLOGIC, INC. By: /s/ Anne M. Liddy Anne M. Liddy General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing